• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Peru: 2023 Mpox

Shiloh

Editor, Senior Moderator
Source: https://www.swissinfo.ch/spa/monopox-perú_perú-reports-a--progressive-decline--in-monkey-pox-cases/ 48296670

Peru reports a "progressive decline" in monkey smallpox cases
This content was published on February 17, 2023 - 21:53 February 17, 2023 - 21:53

Lima, Feb 17 (EFE).- Peru has registered, so far this year, a "progressive decline" in the number of cases of monkeypox detected in the country, in a trend that is also occurring in other nations in the world, reported this Friday the Ministry of Health (Minsa).

The National Center for Epidemiology, Disease Prevention and Control (CDC) of Minsa indicated that the highest number of cases was registered during the epidemiological week from August 7 to 13, 2022, when 313 cases were confirmed in the country.

From January 1 to February 11, 55 cases of the disease have been registered.

The Minsa stressed that despite this trend, epidemiological surveillance will continue at the national level "for the identification and timely discarding of cases to prevent the spread of the disease."

The first confirmed case in Peru was reported on June 26, 2022 and, so far, a total of 3,752 accumulated cases have been registered in 21 regions of the country, with 2,864 of them in Lima, a city of almost 10 million inhabitants.

Of the total confirmed cases, 3,726 patients have already been discharged after completing a 21-day isolation period.

In addition, the CDC indicated that 96.1% (3,606) of the total number of infected are men between 5 and 75 years of age, and 3.9% (146) are women between 2 and 55 years of age.

The Minsa indicated that it continues with the vaccination process against this disease, with priority in vulnerable populations, and until February 15, 16,868 doses of vaccines have been applied, of which 12,120 were a first dose and 4,748 a second dose. .
 
Back
Top